Latanoprost controlled release - Peregrine Ophthalmic

Drug Profile

Latanoprost controlled release - Peregrine Ophthalmic

Alternative Names: Latanoprost extended release -Preregrine Ophthalmic; Latanoprost liposomal - Peregrine Ophthalmic; POLAT 001

Latest Information Update: 04 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Peregrine Ophthalmic
  • Class Antiglaucomas; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin F2 alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Glaucoma; Ocular hypertension

Most Recent Events

  • 04 Aug 2017 Phase II development is ongoing in USA (Peregrine Ophthalmic website, August 2017)
  • 01 Jun 2016 Peregrine Ophthalmic completes an observational, extension clinical trial for Glaucoma and Ocular hypertension in USA (Ophthalmic) (NCT02599688)
  • 01 Apr 2016 Peregrine Ophthalmic completes a phase II trial in Glaucoma and Ocular hypertension in USA (Ophthalmic) (NCT02466399)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top